Immunicon

Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood. It developed the CellSearch and CellTracks diagnostic platforms, licensed to Veridex, LLC (a Johnson & Johnson company) for oncology use. Immunicon filed for Chapter 11 bankruptcy in 2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch platform later passed to Menarini Silicon Biosystems. The company was backed by Canaan Partners and publishes no public API or developer surface.

Immunicon is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Diagnostics, Oncology, and Medical Devices.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyDiagnosticsOncologyMedical DevicesLife SciencesDefunct

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/immunicon: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: immunicon
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immunicon.png
name: Immunicon
description: Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered
  immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood.
  It developed the CellSearch and CellTracks diagnostic platforms, licensed to Veridex, LLC (a Johnson & Johnson company)
  for oncology use. Immunicon filed for Chapter 11 bankruptcy in 2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch
  platform later passed to Menarini Silicon Biosystems. The company was backed by Canaan Partners and publishes no public
  API or developer surface.
url: https://raw.githubusercontent.com/api-evangelist/immunicon/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Diagnostics
- Oncology
- Medical Devices
- Life Sciences
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence